An investigation into same-day surgery centers uncovered deadly risks for patients; Uber is launching a medical ride sharing service; the immortality market is attracting cash as well as plenty of skeptics.
More than 260 patients have died since 2013 after 1-day procedures at surgery centers, according to an investigation by Kaiser Health News and the USA TODAY Network. Some died after routine operations, such as colonoscopies and tonsillectomies, while others died after more risky surgeries, like those performed on or near the spine. The investigation examined autopsy records, legal filings and more than 12,000 state and Medicare inspection records, and reporters interviewed dozens of doctors, health policy experts and patients.
Uber is launching Uber Health, which will allow healthcare providers to schedule rides for patients, the Washington Post reported. No smartphone is necessary. It’s unclear if the service will work to help patients get to their appointments; a study published last month found that a service offering free Lyft rides in Philadelphia didn't decrease the number of missed appointments, compared to a group of people not offered the service. Transfusions of “young blood” into aging people possibly willing to pay big money for it in the hopes of living longer is the latest in a line of business opportunities aimed at the dubious immortality market, according to Stat News. Among the players are a Florida physician, Google’s parent company, a startup called Celularity, and a company called Elysium Health.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More